Evolus EOLS
NASDAQ EOLS
$8.01 +0.02 (+0.25%)
As of: Sep 30, 2026 · 3:59 PM EDT

Evolus (EOLS) Capital Expenditures (2019 - 2026)

Updated

Evolus (EOLS) posted Capital Expenditures of $50,000 for Q2 2026, down 92.7% from $688,000 a year earlier and down 88.0% from the prior quarter.

Analysis

Evolus (EOLS) Capital Expenditures (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Evolus was $2.9 million, up 64.9% year-over-year; for FY2025, it came in at $3.44 million, up 133.8% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of 33.4% (FY2020 to FY2025).
  • In prior years, Evolus' Capital Expenditures was $1.47 million in FY2024 (+211.2%), $473,000 in FY2023 (-70.8%), $1.62 million in FY2022 (+311.7%) and $393,000 in FY2021 (-51.8%).
  • The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q3 2023.
  • On a year-over-year basis, Capital Expenditures increased in seven of the last eight quarters, with growth averaging 192.7%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2024, with growth of 979.3%; the weakest was Q2 2023, with a decline of 96.5%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $415,000 (Q1 2026), $1.48 million (Q4 2025) and $955,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Evolus 527.45 Mn 335.14 Mn 57.18 Mn 50,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50,000.00
Mar 31, 2026 415,000.00
Dec 31, 2025 1.48 Mn
Sep 30, 2025 955,000.00
Jun 30, 2025 688,000.00
Mar 31, 2025 319,000.00
Dec 31, 2024 438,000.00
Sep 30, 2024 313,000.00
Jun 30, 2024 465,000.00
Mar 31, 2024 256,000.00
Dec 31, 2023 209,000.00
Sep 30, 2023 29,000.00
Jun 30, 2023 8,000.00
Mar 31, 2023 227,000.00
Dec 31, 2022 866,000.00
Sep 30, 2022 509,000.00
Jun 30, 2022 231,000.00
Mar 31, 2022 12,000.00
Dec 31, 2021 393,000.00
Dec 31, 2020 17,000.00
API Access

Evolus Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EOLS&period=max&api_key=YOUR_API_KEY